Amiodarone versus Implantable Defibrillator (AMIOVIRT): background, rationale, design, methods, results and implications.

Cardiac electrophysiology review

Volumn 7, Issue 4, 2003, Pages 452-456

  Wijetunga, Mevan ^a   Strickberger, S Adam ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE FREE SURVIVAL; FEMALE; HEART ARRHYTHMIA; HEART STROKE VOLUME; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CARDIOMYOPATHY, DILATED; DEFIBRILLATORS, IMPLANTABLE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; STROKE VOLUME;

EID: 4143065659     PISSN: 13852264     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CEPR.0000023158.52511.76     Document Type: Article

References (0)